The rise of pronatalism: why Musk, Vance and the right want women to have more babies
By Carter Sherman,
The Guardian
| 03. 11. 2025
In his first address to the United States after becoming vice-president, JD Vance stood on stage and proclaimed: “I want more babies in the United States of America.” Weeks later, Donald Trump signed an executive order pledging support for in vitro fertilization, recognizing “the importance of family formation and that our nation’s public policy must make it easier for loving and longing mothers and fathers to have children”.
In late January, a Department of Transportation memo directed the agency to prioritize projects that “give preference to communities with marriage and birth rates higher than the national average”. And last week, it was reported that Elon Musk, the unelected head of the government-demolishing “department of governmental efficiency” and a man who has said that the “collapsing birth rate is the biggest danger civilization faces by far”, had become a father of 14.
Republicans have long heralded the importance of “family values”. But in these developments, many see mounting signs of a controversial ideology at work: pronatalism.
Pronatalism is so contentious that people often struggle to agree...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Angus Liu, Fierce Pharma | 06.16.2025
A second patient has died following treatment with Sarepta Therapeutics’ Elevidys, raising more doubts about the Duchenne muscular dystrophy (DMD) gene therapy’s safety profile.
Sarepta and its ex-U.S. partner Roche reported the death early Sunday. Like the first case, disclosed...
By Sophie Alexander and Ike Swetlitz, Bloomberg | 06.25.2025
A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to one of the most controversial technologies in medicine.
Bootstrap Bio...
